ANMED HEALTH — History
CCN 420027 | 3-year financial timeline | COVID resilience: 21/100
🛡️ Public data only — no PHI permitted on this instance.
$597M
Latest Revenue (FY2022)
-9.5%
Revenue CAGR (3yr)
-2.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $728M | $594M | $597M | +0.5% | -9.5% |
| Operating Expenses | $532M | $585M | $610M | +4.3% | +7.1% |
| Operating Margin | 26.9% | 1.4% | -2.3% | -261.2% | +0.0% |
| Net Income | $196M | $8M | $-14M | -262.0% | +0.0% |
| Licensed Beds | 367 | 367 | 367 | +0.0% | +0.0% |
| Total Patient Days | 83,090 | 86,399 | 82,776 | -4.2% | -0.2% |
| Medicare Day % | 33% | 29% | 26% | -9.8% | -10.6% |
| Medicaid Day % | 5% | 5% | 4% | -9.1% | -8.7% |
COVID Impact & Recovery
Resilience Score: 21/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -18.1% ($728M → $597M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-9.5%
This Hospital
+7.6%
State Avg
Latest Margin
-2.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $531M | -16.9% |
| FY2024 (proj) | $465M | -31.5% |
| FY2025 (proj) | $399M | -46.1% |